ArticleCancers2022

Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma.

Sonia Simón Serrano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.